Registration Dossier

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
calculation (if not (Q)SAR)
Remarks:
Migrated phrase: estimated by calculation
Adequacy of study:
key study
Study period:
2012
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable calculated/extrapolated data

Data source

Reference
Reference Type:
other: Expert opinion
Title:
Unnamed
Year:
2012
Report Date:
2012

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
To assess the acute inhalational toxicity of toluene-2,5-diamine, a kinetic based calculation was done. The kinetic data were derived from various kinetic studies, and the details of the test methods and the results are provided in this summary (refer to executive summary for details). The derived data were consistent with the determined acute toxicity values (derived by in-vivo studies) from p-phenylenediamine, the most appropriate analogue for toluene-2,5-diamine.
Test type:
other: Estimated data by calculation
Limit test:
no

Test material

Reference
Name:
Unnamed
Type:
Constituent
Type:
Constituent
Test material form:
not specified
Details on test material:
- Name of test material: TOLUENE-2,5-DIAMINE is 1,4-phenylene diamine with a single methyl substituent on the benzene ring. Therefore, it is a member of the p-phenylenediamine family.

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LC50
Effect level:
0.99 mg/L air
Based on:
other: kinetic based calculation
Exp. duration:
4 h
Remarks on result:
other: The calculated inhalational LC50 of 0.99 mg/L for toluene-2,5-diamine is comparable to the determined value for p-phenylenediamine (0.92 mg/L)

Applicant's summary and conclusion

Interpretation of results:
Toxicity Category IV
Remarks:
Migrated informationCriteria used for interpretation of results: EU
Conclusions:
Based on the available acute oral toxicity and kinetic data for toluene-2,5-diamine, the extrapolated acute inhalation toxicity (4 h, LC50) of toluene-2,5-diamine was 0.99 mg/L. This value is comparable to the determined value for p-phenylenediamine (0.92 mg/L).
Executive summary:

To assess the acute dermal and inhalational toxicity of toluene-2,5-diamine, a kinetic based calculation was done. The kinetic data were derived from various kinetic studies, and the details of the test methods and the results are provided in the SCCS Opinion1479/12, 26 – 27June 2012.In addition, the calculated data for toluene-2,5-diamine were compared with those of the most appropriate analogue, the p-phenylenediamine (refer to below table).

COLIPA Number

Chemical Name

CAS Number

Acute Toxicity

Oral

LD50

Dermal

LD50

Inhalation LC50

Colipa No. A005

 

 

 

Toluene-2,5-Diamine

95-70-5 (free base)

102 mg/kg bw

(rat)

> 2000 mg/ kg bw

(rat, extrapolated)

0.99 mg/l,

 (4h, rat, extrapolated)

Colipa No. A007

 

 

p-Phenylenediamine

106-50-3 (free base)

80-100 mg/kg bw

(rat)

> 7940 mg/kg bw

(male/female rabbit)

0.92 mg/l air

(4 h ,rat)

Studies used for the determination of acute toxicity of TOLUENE-2,5-DIAMINE:

Acute Oral Toxicity study result

LD50oral: 102 mg/kg bw in the rat (CFY strain); “The acute median lethal oral dose was calculated to be 102 mg/kg bw (95% confidence limits of 69-152 mg/kg bw)”

Toxicokinetic study results in Sprague Dawley rats:

Dose levels:

IV: 2.5 mg/kg bw

Oral: 2.5, 25 mg/kg bw

Dermal:0.5 mg/cm² equal to 33.3 mg/kg bw

Bioavailability, assuming 100% bioavailability IV

Oral dosing: 69 %

Dermal dosing: 2 %

The studies are summarized as follows in SCCS 1479/12:

“In toxicokinetic studies with Sprague-Dawley rats the comparison of AUCs showed differences between oral (25 mg/kg bw: 112 mgeqx h/l) and dermal application (33 mg/kg bw in formulation: 2.27 mgeqx h/l). Following 2.5 mg/kg bw the AUC was 8.53 mgeqx h/l. The bioavailability (derived from comparison to iv administration) after oral dosing of 10 mg/kg bw was 69% while 2% bioavailability was found after dermal administration in a formulation.”

This summary provides calculation ofextrapolation of the acute inhalation toxicity of toluene-2,5-diamine. The summary of calculation of extrapolation of the acute dermal toxicity is provided under section 7.2.3 of IUCLID.

 

Extrapolation of the acute inhalational toxicity of TOLUENE-2,5-DIAMINE:

Required maximum exposure concentration to test material (OECD 403):           5 mg/L

Assumed body weight of the rat for the calculation:                                            250 g

Respiratory volume of the rat:                                                                            0.074 L/min

Required duration (OECD 403):                                                                          4 h

0.074 L/min x 60 min x 4 hour = 17.76L

Toluene-2,5-diamine LD50oral= 102 mg/kg bw in the rat

Calculation:

Maximum achievable exposure regarding required 5 mg/L for 4 hours (OECD 403:

17.76 L x 5 mg/L = 88.8 mg/rat

88.8 mg/0.250 kg bw = 355 mg/kg bw maximum achievable exposure

Oral Bioavailability = 69% (at 25 mg/kg bw, using the data from the toxicokinetic study in Sprague Dawley rats)

Inhalation Bioavailability: Assumed to be 100%

Determination of the correction factor oral vs. inhalation route:

69% oral vs. 100% inhalation = 0.69

LC50 calcinhal.: 102 mg/kg bw x 0.250 kg bw x 0.69/17.76 L = 0.99 mg/L

LC50inhal. forp-phenylenediamine =  0.92 mg/L

LC50 calcinhal. for toluene-2,5-diamine = 0.99 mg/L

The calculated inhalational LC50of 0.99 mg/L for toluene-2,5-diamine is comparable to the determined value forp-phenylenediamine (0.92 mg/L)

The calculated inhalation toxicity value for toluene-2,5-diamine is in the same order of magnitude (0.99 mg/l calculated versus 1.0-5.0 mg/l) as the official classification of Acute Tox Cat 4; H332 in Annex VI of the CLP regulation which is being applied in case of 1 mg/L<LC50<5 mg/L (for dusts/mists).

ASSESSMENT OF VALIDITY:

Since theWeight of Evidence Approach (WoE)used was considered as sufficiently robust to determine the acute inhalation toxic potential of toluene-2,5-diamine, the performance of an animal test for hazard identification purposes was considered to be not justified

In addition the completion of acute toxicity studies ontoluene-2,5-diamine as an ingredient used in cosmetic products would not be considered to comply with the EU regulations regarding animal testing. Furthermore, applying WoE complies with the REACH regulation to avoid animal testing. The validity of the WoE/extrapolation approach used in order to estimate the acute toxicity potential of toluene-2,5-diamine by inhalation route was finally confirmed by the comparison of the extrapolated values on toluene-2,5-diamine with experimental values obtained on the primary member of thep-phenylenediamine family,p-phenylenediamine.

In conclusion, the extrapolated acute inhalation toxicity (4 h, LC50) of toluene-2,5-diamine was 0.99 mg/L. This value is comparable to the determined value for p-phenylenediamine (0.92 mg/L)